BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18344085)

  • 1. [Study on the mechanism of DDP-resistance mediated by phosphate JNK in gastric cancer].
    Li DW; Peng ZH; Li ZZ; Zhang YH; Zhao MZ; Wu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):159-62. PubMed ID: 18344085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
    Lian C; Yang J; Wang X; Xie Y; Xiao Q
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms.
    Zhu ZA; Zhu ZQ; Cai HX; Liu Y
    Asian Pac J Cancer Prev; 2012; 13(2):625-31. PubMed ID: 22524836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing effect of NOTCH1 inhibitor LY3039478 on drug-resistance cells SGC7901/DDP of human gastric cancer and its mechanism.
    Wang YL; Zhang Y; Huang XY; Zheng Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4121-4127. PubMed ID: 30024600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells].
    Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
    Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
    Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
    Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
    Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
    Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
    Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
    Zhu QL; Li Z; Lv CM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
    Tang T; Song X; Liu YF; Wang WY
    Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
    Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
    J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance reversal in human gastric carcinoma cells by neferine.
    Cao JG; Tang XQ; Shi SH
    World J Gastroenterol; 2004 Oct; 10(20):3062-4. PubMed ID: 15378795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].
    Han J; Tan BB; Geng W; Lu BR; Zhao JH
    Ai Zheng; 2008 Nov; 27(11):1166-71. PubMed ID: 19000447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi].
    Zhang J; Ji J; Ji YB; Yuan F; Liu BY; Zhu ZG; Lin YZ
    Ai Zheng; 2005 Apr; 24(4):432-7. PubMed ID: 15820065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.